HCL Revenue and Competitors
Estimated Revenue & Valuation
- HCL's estimated annual revenue is currently $1.4M per year.
- HCL's estimated revenue per employee is $50,750
Employee Data
- HCL has 27 Employees.
- HCL grew their employee count by 4% last year.
HCL's People
Name | Title | Email/Phone |
---|
HCL Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $6.7M | 92 | -4% | N/A | N/A |
#2 | $124.9M | 1205 | 24% | $177.6M | N/A |
#3 | $121.5M | 1172 | -3% | $250M | N/A |
#4 | $21.2M | 266 | 23% | N/A | N/A |
#5 | $46.2M | 510 | 27% | N/A | N/A |
#6 | $1207.7M | 11649 | 14% | $1.7B | N/A |
#7 | $312.7M | 3016 | 8% | $113.8M | N/A |
#8 | $6.8M | 94 | -24% | N/A | N/A |
#9 | $23.9M | 300 | -2% | N/A | N/A |
#10 | $307.7M | 3032 | 8% | N/A | N/A |
What Is HCL?
H. C. L Technologies is an information technology and services company based out of D/91 Laxmi Nagar, New Delhi, Delhi, India.
keywords:N/AN/A
Total Funding
27
Number of Employees
$1.4M
Revenue (est)
4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
HCL News
2022-04-19 - Pfizer Voluntary Nationwide Recall of Lots of ACCUPRIL ...
Pfizer is voluntarily recalling five (5) lots of Accupril (Quinapril HCl) tablets distributed by Pfizer to the patient (consumer/user) level...
2022-04-19 - Can HCL Technologies' stock make strong recovery after 3x jump in Q4 profit?
Can HCL Technologies' stock make strong recovery after 3x jump in Q4 profit? By. Amit Mudgill. , ETMarkets.com Last Updated: Apr 22, 2022, 02:14...
2022-04-19 - Why HCL Tech Management is comfortable with a 12-14% revenue guidance for
FY23
C Vijayakumar, CEO & MD, and Prateek Aggarwal, CFO, HCL Technologies, in conversation with ET Now after the announcement of the Q4 results.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 27 | 4% | N/A |
#2 | $1M | 27 | 13% | N/A |
#3 | $1.2M | 27 | 4% | N/A |
#4 | $1.7M | 27 | N/A | N/A |
#5 | $1.4M | 27 | 8% | N/A |